Global Autism Drug Market Companies

Healthcare
May 2025
Global
350 Pages
No of Tables:
No of Figures:

Buy Now

Request for Sample

Nucleus

Companies Covered

Highest Market Share

Dominant Companies

Other Companies

Global Autism Drug Market Share Analysis

The data presented is for visualization purposes only and may not reflect actual results.

Nucleus : Company Analysis Platform

Request for Demo >

Frequently Asked Questions

Who are major players in the Autism Drug Market?

Companies like Otsuka Pharmaceutical, Johnson & Johnson, Roche, Novartis, and Curemark are the major companies in the Autism Drug Market.

What are the recent product launches by major companies in the Autism Drug Market?

• In January 2022, Otsuka Pharmaceutical launched a long-acting injectable version of aripiprazole for irritability associated with autism in children. • In April 2023, Acadia Pharmaceuticals announced the expansion of its autism-focused pipeline following positive trial data. • In October 2021, GW Pharmaceuticals introduced a cannabinoid-based oral therapy for behavioral symptoms in autism spectrum disorders. • In 2023, Neurochlore and a French telehealth startup launched a digital companion app to track treatment outcomes in children on autism medications.

Which countries' data is covered in the Autism Drug Market?

The countries covered in the Autism Drug Market are North America: U.S., Canada, Mexico ,Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe,China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and AfricaBrazil, Argentina, Rest of South America